Filament Health Corp. announced a private placement of 20,000,000 common shares at a price of CAD 0.05 per share for the gross proceeds of CAD 1,000,000 on June 3, 2024. The transaction will include participation from returning investor, Negev Capital Fund One L.P. Fund, a fund managed by, Negev Capital and chief executive officer of the company, Benjamin Lightburn, will purchase 2,700,000 common shares for the gross proceeds of CAD 100,000.

The common shares issued to Lightburn will be subject to a four-month-and-one-day hold period in accordance with applicable securities laws. The transaction is subjected to regulatory approval, including the approval of CBOE Canada, and is expected to close on or about June 10, 2024.